chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tremor
Clinical narrative: sleeping up to 14 hours a day; pain in both arms but especially the left one; extreme fatigue; muscle weakness; difficulty getting out of chair; puffiness in her feet; hand tremors; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (hand tremors), MUSCULAR WEAKNESS (muscle weakness), HYPOKINESIA (difficulty getting out of chair), OEDEMA PERIPHERAL (puffiness in her feet) and HYPERSOMNIA (sleeping up to 14 hours a day) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dementia (The patient suffers from dementia, Site is worsening) since 2013, Hyperlipidemia (no recent changes) and Arthritis (increased pain, stiffness, difficulty getting up from chair, hand tremors since covid vaccines given). Concomitant products included DONEPEZIL for Dementia, VITAMIN B12 [VITAMIN B12 NOS] for Memory disturbance and Nerve damage.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness), HYPOKINESIA (difficulty getting out of chair) and FATIGUE (extreme fatigue). In 2021, the patient experienced TREMOR (hand tremors) and OEDEMA PERIPHERAL (puffiness in her feet). On an unknown date, the patient experienced HYPERSOMNIA (sleeping up to 14 hours a day) and PAIN IN EXTREMITY (pain in both arms but especially the left one). At the time of the report, TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of chair), OEDEMA PERIPHERAL (puffiness in her feet), HYPERSOMNIA (sleeping up to 14 hours a day), PAIN IN EXTREMITY (pain in both arms but especially the left one) and FATIGUE (extreme fatigue) had not resolved and MUSCULAR WEAKNESS (muscle weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Vitamin B12 gummies of 500 mcg were also taken as concomitant medication for memory and nerve function from  March 2021 and still ongoing  The symptoms mentioned previously (extreme tiredness, weakness, hand tremors, difficulty getting out of a chair, sleeping up to 14 hours a day, pain in extremities-epecially the left arm all started after the patient received the moderna vaccine.  It started with the first vaccine and is ongoing and has not resolved.  She saw her primary care doctor on 4/27/2021 who only said that he had not heard of the covid vaccine causing such symptoms for an extended period of time.  He also did not know whether the vaccine triggered worsening of her dementia.  The puffiness in her feet started around the last week of April.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Significant:Additional AE, medical history, con med updated
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia, Nodule
Clinical narrative: Found a little pea size knot on my left clavicle/Nodule still present; got the second shot on day 38; general mild soreness; This spontaneous case was reported by a consumer and describes the occurrence of NODULE (Found a little pea size knot on my left clavicle/Nodule still present), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second shot on day 38) and MYALGIA (general mild soreness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced MYALGIA (general mild soreness). On an unknown date, the patient experienced NODULE (Found a little pea size knot on my left clavicle/Nodule still present) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second shot on day 38). On 07-Apr-2021, MYALGIA (general mild soreness) had resolved. At the time of the report, NODULE (Found a little pea size knot on my left clavicle/Nodule still present) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the second shot on day 38) outcome was unknown.            No concomitant medications reported.   No treatment information were reported.  The action taken with mRNA-1273 in response to events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Update on AE ( Node on the clavicle has reduced in size but it was not gone) On 19-May-2021: Patient denied Email and additional information on event was added.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (soreness of the right arm) and extreme headache in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 017B21A) for COVID-19 immunization. Concomitant products included amlodipine for an unknown indication. On Apr 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 6, 2021, patient experienced pain in extremity (soreness of the right arm) and extreme headache. The patient treated with Tylenol (paracetamol), ongoing since an unknown date; 1 dosage form. At the time of the report, pain in extremity (soreness of the right arm) and extreme headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine):  unknown. Patient stated the headache felt like a bad migraine and had to skip work.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pain, Pain in extremity
Clinical narrative: has been having a lot of pain; sharp pain in her back; sharp pain in her left arm; sharp pain in her left hand; sharp pain in her shoulder; sharp pain in her left wrist; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (has been having a lot of pain), BACK PAIN (sharp pain in her back), PAIN IN EXTREMITY (sharp pain in her left arm), PAIN IN EXTREMITY (sharp pain in her left hand) and ARTHRALGIA (sharp pain in her shoulder) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METHOTREXATE SODIUM (METHOTREXATE [METHOTREXATE SODIUM]), PREDNISONE, FOLIC ACID, INFLIXIMAB, ACETYLSALICYLIC ACID (BABY ASPIRIN), POTASSIUM (POTASSIUM 99), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), LATANOPROST, TIMOLOL MALEATE (LATANOPROST & TIMOLOL MALEATE) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (has been having a lot of pain), BACK PAIN (sharp pain in her back), PAIN IN EXTREMITY (sharp pain in her left arm), PAIN IN EXTREMITY (sharp pain in her left hand), ARTHRALGIA (sharp pain in her shoulder) and ARTHRALGIA (sharp pain in her left wrist). The patient was treated with PREDNISONE at an unspecified dose and frequency and CORTISONE at a dose of cortisone shot given. At the time of the report, PAIN (has been having a lot of pain), BACK PAIN (sharp pain in her back), PAIN IN EXTREMITY (sharp pain in her left arm), PAIN IN EXTREMITY (sharp pain in her left hand), ARTHRALGIA (sharp pain in her shoulder) and ARTHRALGIA (sharp pain in her left wrist) outcome was unknown.            .The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash, Syncope
Clinical narrative: feeling of syncope; Rash in all over her body; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), RASH (Rash in all over her body) and SYNCOPE (feeling of syncope) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Celiac disease. Concomitant products included PREGNAZON for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced HEADACHE (Headache). On 05-Apr-2021, the patient experienced RASH (Rash in all over her body). On 13-Apr-2021, the patient experienced SYNCOPE (feeling of syncope). On 14-Apr-2021, RASH (Rash in all over her body) had resolved. On 28-Apr-2021, SYNCOPE (feeling of syncope) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment to the events not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: follow up received on 1-jun-2021 patient demographic details, historical diseases, new events, outcome of the events are updated.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Myalgia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported.  On Feb 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 19, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 20, 2021, patient experienced insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain). At the time of the report,  insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain) outcome: unknown. No concomitant medication or treatment information provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash macular
Clinical narrative: Pink reddish blotch the size of a hand; Half of the blotch is raised and has a border around half of it; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Pink reddish blotch the size of a hand) and PERIPHERAL SWELLING (Half of the blotch is raised and has a border around half of it) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 07-Apr-2021, the patient experienced RASH MACULAR (Pink reddish blotch the size of a hand) and PERIPHERAL SWELLING (Half of the blotch is raised and has a border around half of it). At the time of the report, RASH MACULAR (Pink reddish blotch the size of a hand) and PERIPHERAL SWELLING (Half of the blotch is raised and has a border around half of it) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.        relevant concomitant products included blood pressure medications, thyroid medications, waterpure. Treatment details not included.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Ocular discomfort, Rhinorrhoea
Clinical narrative: Nose blows; The both eyes discomfort; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RHINORRHOEA (Nose blows) and OCULAR DISCOMFORT (The both eyes discomfort) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced RHINORRHOEA (Nose blows) and OCULAR DISCOMFORT (The both eyes discomfort). On 07-Apr-2021, RHINORRHOEA (Nose blows) and OCULAR DISCOMFORT (The both eyes discomfort) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to INC.-MOD-2021-069919 (E2B Linked Report).; Sender's Comments: INC.-MOD-2021-069919:Case for first dose.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 30-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Patient reported having no health conditions or allergies.). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Prenatal care.    On 06-Apr-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-May-2021. On 06-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). On 06-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I received my 2nd dose on April 1st; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 2nd dose on April 1st) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     Concomitant products included BUDESONIDE, POTASSIUM CHLORIDE, METOPROLOL TARTRATE (LOPRESSOR), CALCIUM, MULTIVITAMIN [VITAMINS NOS], IRON and CYANOCOBALAMIN (B12-VITAMIIN) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 2nd dose on April 1st). On 01-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 2nd dose on April 1st) had resolved.            No treatment medication was reported by reporter.  Due to hospitalization for acute pancreatitis patient could not get second shot in 28 days window and took it 42 days after.   This case was linked to MOD-2021-062263 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Follow-up was received and contains no new information.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Sore area of injection; Red area of injection; arm of injection was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm of injection was a little sore), VACCINATION SITE PAIN (Sore area of injection) and VACCINATION SITE ERYTHEMA (Red area of injection) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm of injection was a little sore). On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore area of injection) and VACCINATION SITE ERYTHEMA (Red area of injection). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm of injection was a little sore), VACCINATION SITE PAIN (Sore area of injection) and VACCINATION SITE ERYTHEMA (Red area of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information also includes Ice Pack
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 1) who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Apr-2021. On 15-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). On 15-Mar-2021, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment medications provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Mass, Pain in extremity, Rash, Vaccination site pain
Clinical narrative: Shingles; Rashes started to appear on the left arm which has already cleared up; Little bump showed up close to the wrist and just went up from there; Pain started on her left arm from the injection site; Right arm hurt bad; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Right arm hurt bad), HERPES ZOSTER (Shingles), MASS (Little bump showed up close to the wrist and just went up from there), RASH (Rashes started to appear on the left arm which has already cleared up) and VACCINATION SITE PAIN (Pain started on her left arm from the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 013M20A) for COVID-19 immunisation.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included VITAMINS NOS for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm hurt bad) and VACCINATION SITE PAIN (Pain started on her left arm from the injection site). On 09-Mar-2021, the patient experienced MASS (Little bump showed up close to the wrist and just went up from there). On 10-Mar-2021, the patient experienced RASH (Rashes started to appear on the left arm which has already cleared up). On an unknown date, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, PAIN IN EXTREMITY (Right arm hurt bad), HERPES ZOSTER (Shingles) and MASS (Little bump showed up close to the wrist and just went up from there) outcome was unknown, RASH (Rashes started to appear on the left arm which has already cleared up) had resolved and VACCINATION SITE PAIN (Pain started on her left arm from the injection site) had not resolved.            Treatment information included different soaps for rashes, CBD lotion and oil for pain. The patient was prescribed with antibiotics and gabapentin for pain, both to treat shingles. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration
Clinical narrative: pinkish color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (pinkish color) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (pinkish color). At the time of the report, VACCINATION SITE DISCOLOURATION (pinkish color) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication reported.  Treatment information not provided.   Reporter did not allow further contact
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Disturbance in attention, Dizziness, Erythema
Clinical narrative: Patient is having trouble moving her injection site arm; injection site arm red; swollen arm; inability to concentrate; Dizziness; Fever of 103 Degrees Farenheight; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate) and DIZZINESS (Dizziness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included ACETAMINOPHEN and IBUPROFEN for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 103 (High) 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasticity, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Patient is having trouble moving her injection site arm; injection site arm red; swollen arm; inability to concentrate; Dizziness; Fever of 103 Degrees Farenheight; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate) and DIZZINESS (Dizziness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included ACETAMINOPHEN and IBUPROFEN for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, MUSCLE SPASTICITY (Patient is having trouble moving her injection site arm), ERYTHEMA (injection site arm red), PERIPHERAL SWELLING (swollen arm), DISTURBANCE IN ATTENTION (inability to concentrate), DIZZINESS (Dizziness), PYREXIA (Fever of 103 Degrees Farenheight), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 103 (High) 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Interchange of vaccination products; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccination products) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccination products). On 07-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccination products) had resolved. Unknown          concomitant medicines was not reported by reporter   treatment information was not provided   The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (intramuscular), the reporter did not provide any causality assessments.  patient had taken first dose of Pfizer on 10mar2021,on the same locations for both the doses    Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up received on 16-JUNE-2021.contai ns no new information
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Reaction to the protein of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction to the protein of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction to the protein of the vaccine). At the time of the report, VACCINATION COMPLICATION (Reaction to the protein of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication information was reported. Caller said her doctor has only had three people who have experienced this type of reaction and told her to call moderna. They react to the protein in the vaccine.   This case was linked to MOD21-071283, MOD21-059914 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow-up received on 20-May-2021: contains no new information(NNI).; Sender's Comments:  MOD21-071283: MOD21-059914:
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: boss had an allergic reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (boss had an allergic reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (boss had an allergic reaction). At the time of the report, HYPERSENSITIVITY (boss had an allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: pain; few aches; sore arm; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY, PAIN, and PAIN in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY. On an unknown date, the patient experienced PAIN and PAIN. At the time of the report, PAIN IN EXTREMITY, PAIN, and PAIN outcome was unknown. Not Provided.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs are not provided. Treatment drug information does not provided. The action taken with the drug was not applicable.   Reporter did not allow further contact.
Sex: U
Vaccine: COVID19
Symptoms: Accidental exposure to product
Clinical narrative: Eye exposure to the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT. At the time of the report, ACCIDENTAL EXPOSURE TO PRODUCT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment was not reported/ unknown.  This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.   Reporter did not allow further contact. Sender's Comments: This report refers to a case of expired product administered for mRNA-1273 with no associated AEs.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Hyperhidrosis, Pain in extremity
Clinical narrative: sweatiness; Arm  hurt so bad; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweatiness) and PAIN IN EXTREMITY (Arm  hurt so bad) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021E21A and 021B21A) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweatiness) and PAIN IN EXTREMITY (Arm  hurt so bad). At the time of the report, HYPERHIDROSIS (sweatiness) and PAIN IN EXTREMITY (Arm  hurt so bad) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, COVID-19: positive (Positive) Positive.         No concomitant medications and treatment information were reported.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: body pain in the left arm; sore throat; body pain; headache; fever of 100; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache) and PYREXIA (fever of 100 ) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 023M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache), PYREXIA (fever of 100 ) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache), PYREXIA (fever of 100 ) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 100 (High) 100.         No concomitant medications were reported.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: body pain in the left arm; sore throat; body pain; headache; fever of 100; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache) and PYREXIA (fever of 100 ) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 023M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache), PYREXIA (fever of 100 ) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (body pain in the left arm), OROPHARYNGEAL PAIN (sore throat), MYALGIA (body pain), HEADACHE (headache), PYREXIA (fever of 100 ) and CHILLS (chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 100 (High) 100.         No concomitant medications were reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Cough, Dizziness
Clinical narrative: constantly cold and could not get warm; head felt like it had swelled up; sore arm; swollen arm; aches in her bones ,joints and muscles; constantly cold and could not get warm; dizziness; Headache; nausea; tired; chills; aches in her bones ,joints and muscles; aches in her bones ,joints and muscles; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm) and BONE PAIN (aches in her bones ,joints and muscles) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nasopharyngitis, Nausea
Clinical narrative: constantly cold and could not get warm; head felt like it had swelled up; sore arm; swollen arm; aches in her bones ,joints and muscles; constantly cold and could not get warm; dizziness; Headache; nausea; tired; chills; aches in her bones ,joints and muscles; aches in her bones ,joints and muscles; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm) and BONE PAIN (aches in her bones ,joints and muscles) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Swelling, Vaccination site erythema
Clinical narrative: constantly cold and could not get warm; head felt like it had swelled up; sore arm; swollen arm; aches in her bones ,joints and muscles; constantly cold and could not get warm; dizziness; Headache; nausea; tired; chills; aches in her bones ,joints and muscles; aches in her bones ,joints and muscles; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm) and BONE PAIN (aches in her bones ,joints and muscles) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, NASOPHARYNGITIS (constantly cold and could not get warm), SWELLING (head felt like it had swelled up), PAIN IN EXTREMITY (sore arm), PERIPHERAL SWELLING (swollen arm), BONE PAIN (aches in her bones ,joints and muscles), COUGH (constantly cold and could not get warm), DIZZINESS (dizziness), HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tired), CHILLS (chills), MYALGIA (aches in her bones ,joints and muscles), ARTHRALGIA (aches in her bones ,joints and muscles) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: Swollen arm; Itchy arm; red arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PRURITUS (Itchy arm) and ERYTHEMA (red arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), PRURITUS (Itchy arm) and ERYTHEMA (red arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PRURITUS (Itchy arm) and ERYTHEMA (red arm) outcome was unknown. Not Provided          No relevant concomitant medication was reported.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-069974 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069974:second case
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Heart rate increased, Pain, Pruritus
Clinical narrative: rapid pulse; bloody nose; itchy around mouth and chin; very achy; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid pulse), EPISTAXIS (bloody nose), PRURITUS (itchy around mouth and chin) and PAIN (very achy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (rapid pulse), EPISTAXIS (bloody nose), PRURITUS (itchy around mouth and chin) and PAIN (very achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (rapid pulse), EPISTAXIS (bloody nose), PRURITUS (itchy around mouth and chin) and PAIN (very achy) outcome was unknown.            Concomitant medications were not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of hyperhidrosis (sweating after getting vaccination), chills (little bit chills) and vaccination site pain (second shot never hurt like first but can feel it) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 021B21A and 021E21A) for COVID-19 immunization. The patient's past medical history included open heart surgery. On Mar 3, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Apr 4, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Apr 4, 2021, patient experienced hyperhidrosis (sweating after getting vaccination), chills (little bit chills) and vaccination site pain (second shot never hurt like first but can feel it). At the time of the report, hyperhidrosis (sweating after getting vaccination), chills (little bit chills) and vaccination site pain (second shot never hurt like first but can feel it) outcome: unknown/not provided. Diagnostic results: On Apr 7, 2021, SARS-CoV-2 test: Positive. The patient tested COVID-19 positive. No concomitant medication or treatment information provided.The action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable. This case linked to MOD-2021-069943 (patient link).